Bangladesh patient decline persists
Bangladesh patient footfall dropped, causing 1.5% revenue impact; management is exploring other international markets but recovery timeline uncertain.
medium · management_commentary
Apollohosp Ltd — Q3 FY25
Apollo Hospitals delivered a strong Q3 FY25 with consolidated revenue of INR 5,527 crore (+14% YoY) and EBITDA of INR 762 crore (+24% YoY).
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Digital pharmacy competitive pressure
Analyst raised concerns about high ESOP costs and competition from startups; management acknowledged but defended ESOP as retention tool.
medium · analyst_questionNew bed ramp-up risk
Large capacity addition (1,737 beds) could pressure margins if occupancy ramps slower than expected; management expects 100 bps margin impact.
medium · data_observation